Evolus (NASDAQ: EOLS) reported Q2 EPS of ($0.12), $0.08 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $84.08 million versus the consensus estimate of $81.89 million.

GUIDANCE:

Evolus sees FY2026 revenue of $330-337 million, versus the consensus of $330.5 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.